Biotech

Medicine launch pricing is a critical aspect of the pharmaceutical industry that can significantly influence a new drug's success in...

In the rapidly evolving world of pharmaceuticals, effective CDMO vendor management has become a cornerstone for success in contract development...

Biosimilar development challenges are a critical concern within the pharmaceutical industry as companies strive to bring these complex biological products...

Generics in emerging markets represent a pivotal solution to the pressing issue of access to medicines, where affordability and availability...

- 100% of participants were responsive to treatment and 71% of participants were in remission at 12 months after just...

Minimal residual disease (MRD) assessment has emerged as a game-changing biomarker in the multiple myeloma (MM) treatment landscape. Over the...

Boston Pharmaceuticals' next-generation, long-acting FGF21 analog, efimosfermin alfa (BOS-580), has demonstrated positive results in a Phase 2 trial for metabolic...

Single dose of RN0191 achieved up to 95% individual maximum and 87% mean maximum PCSK9 reduction, and up to 74%...

Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products BURLINGTON, Mass., Nov. 14, 2024 /CNW/...

- Company to host conference call and webcast at 8:00 a.m. ET on Monday, November 18, 2024 - - Presentation will also include discussion...